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ABBREVIATIONS
ERP Event-related potentials
Hb Hemoglobin
IDA Iron-deficiency anemia
SES Socio-economic status
AIM The aim of this study was to assess the effects of iron-deficiency anemia (IDA) in infancy
on executive functioning at age 10 years, specifically inhibitory control on the Go/No-Go task.
We predicted that children who had IDA in infancy would show poorer inhibitory control.
METHOD We assessed cognitive inhibitory control in 132 Chilean children (mean [SD] age
10y [1mo]): 69 children had IDA in infancy (45 males, 24 females) and 63 comparison children
who did not have IDA (26 males, 37 females). Participants performed the Go/No-Go task with
event-related potentials. Group differences in behavioral (accuracy, reaction time) and
electrophysiological outcomes (N2 and P300 components) were analyzed using repeated-
measures analyses of variance. N2 and P300 are interpreted to reflect attention and resource
allocation respectively.
RESULTS Relative to comparison participants, children who had IDA in infancy showed
slower reaction time (mean [SE], 528.7ms [14.2] vs 485.0ms [15.0], 95% confidence interval
[CI] for difference between groups 0.9–86.5); lower accuracy (95.4% [0.5] vs 96.9% [0.6], 95%
CI 3.0 to 0.1); longer latency to N2 peak (378.9ms [4.9] vs 356.9ms [5.0], 95% CI 7.5–36.6);
and smaller P300 amplitude (4.5lV [0.8] vs 7.6lV [0.9], 95% CI5.5 to 0.5).
INTERPRETATION IDA in infancy was associated with slower reaction times and
poorer inhibitory control 8 to 9 years after iron therapy. These findings are consistent with
the long-lasting effects of early IDA on myelination and/or prefrontal–striatal circuits where
dopamine is the major neurotransmitter.
The ability to inhibit inappropriate responses is crucial for
optimal cognitive and social-emotional functioning1,2 Sev-
eral neurotransmitters and brain regions are involved, but
dopamine and prefrontal–striatal circuits are arguably the
most important.3,4 Since iron-deficiency anemia (IDA) dur-
ing early development adversely affects the cortex, stria-
tum, and dopaminergic functioning, we undertook the
present study to determine if there are long-term effects
on inhibitory control and response inhibition.5
Inhibitory control is one of the earliest executive func-
tions to begin developing.1,6,7 Its development has been
studied electrophysiologically using event-related potentials
(ERPs) in tasks that require active inhibition when there is a
previously learned or prepotent response.8 Many such stud-
ies have used the Go/No-Go task to assess inhibitory
control.9,10 The main relevant ERP components are the N2
and P300. The N2, an early negative deflection, has been
interpreted to reflect attention. The P300, a later positive
wave, is thought to reflect resource allocation. Attention and
resource allocation are critical abilities with respect to cog-
nitive development and long-term neurofunctional out-
comes. The P300 is typically greater in the inhibitory than
in the prepotent response components of tasks such as the
Go/No-Go task, particularly in adult studies.11,12 Behavioral
responses such as accuracy and reaction time have also been
studied as measures of development.13 We assessed cogni-
tive inhibitory control using the Go/No-Go task in a fol-
low-up study of 10-year-old children who did or did not
have IDA as infants. In light of the protracted development
of higher-order cognitive functions, the important role of
dopamine in inhibitory control, and the short-term and
long-term brain and behavioral effects of early IDA, we
hypothesized that children who had IDA in infancy would
show poorer inhibitory control than comparison partici-
pants. We also predicted longer reaction time owing to the
long-lasting effects of early IDA on myelination.14
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METHOD
Participants
Children in this follow-up study had participated in
previous research on the behavioral, developmental, and
neurofunctional effects of IDA in infancy. Detailed
descriptions of the population and findings during infancy
have been published elsewhere.14 In brief, study partici-
pants were healthy, term-born infants (birth weight >3.0
kg, no perinatal complications, and no acute or chronic ill-
nesses) identified as having IDA or not at 6, 12, or
18 months. Anemia was defined as venous hemoglobin
(Hb) of 100g/L or less at 6 months and less than 110g/L
at 12 months and 18 months. Iron deficiency was defined
as two of three iron measures in the iron-deficient range
(mean cell volume <70fL, erythrocyte protoporphyrin
 100μg/dL red blood cells [1.77μmol/L], serum ferritin
<12μg/L) and/or an increase in Hb  10g/L after
6 months of iron therapy. For each infant with IDA, the
next infant of the same age who was clearly nonanemic
(venous Hb  115g/L) was invited to join the study as part
of the comparison group. The participants were given oral
iron (15mg/d or 30mg/d, depending on age) for a mini-
mum of 6 months and had normal Hb concentrations at
the end of the study. Infants from the comparison group
were given iron to prevent iron deficiency with advancing
age in this setting where iron deficiency was widespread.
Between 2002 and 2006, we conducted neurocognitive
testing with ERPs and collected blood to determine iron
status of the children at 10 years. Of the available 10-year-
old children who had been part of the earlier study (6, 12,
and 18mo IDA, and comparison groups), 72% agreed to
participate, 7% declined further participation, and 21%
could not be located or had moved outside the region.
The protocol was approved by the institutional review
boards of the University of Michigan, Ann Arbor, and the
Institute of Nutrition and Food Technology (INTA),
University of Chile, Santiago. Parents provided signed
informed consent; children gave their assent.
Iron status at age 10 years
IDA was, again, defined as low Hb and two or more
abnormal iron measures, using cut-offs for age
(Hb 11.8g/dl, mean corpuscular volume  76fL, transfer-
rin saturation  14%, free erythrocyte protoporphyrin
 70μg per dl red blood cells [1.24μmol/l], and serum
ferritin [ 12μg/l]). Only three children had IDA at age 10
years; they were excluded from further analyses.
Inhibitory task (Go/No-Go)
Children were seated in front of a computer and were
asked to press a button in response to the presentation of
all letters (target stimuli) except for the letter ‘X’ (non-
target stimuli), while trying to avoid mistakes. Each trial
consisted of a single white upper-case letter presented in
the center of a black computer screen. There were two
blocks of trials: block 1 consisted of 40 trials containing
100% target stimuli (Go trials). These trials primed partic-
ipants to respond to the target stimuli. Block 2 comprised
80 trials containing 50% target stimuli (Go trials) and
50% non-target stimuli (No-Go trials), corresponding to
the response inhibition condition.12
ERPs were recorded from scalp electrodes (Electro-Cap
International, Eaton, OH, USA) referenced to Cz (central
scalp electrode) during acquisition. Data were also
recorded at the left and right mastoids. To detect eye-
blinks, bipolar vertical electro-oculography was carried out
using electrodes placed vertically above and below the right
eye. Electroencephalography (EEG) and electro-oculogra-
phy were conducted using a Neurodata Acquisition System
(Grass Instruments, West Warwick, RI, USA) and ampli-
fied with Model 15 amplifiers with a gain of 50 000 for the
scalp channels and 5000 for the electro-oculographic chan-
nels. The amplifier filter settings were 0.1 to 30.0Hz with
a 50Hz notch filter. All channels were digitized at 200Hz
onto a hard drive with a 12-bit A/D converter (National
Instruments, Austin, TX, USA). ERP data were edited off-
line with ERP32 analysis software (New Boundary Tech-
nologies, Minneapolis, MN, USA). Each trial lasted
1600ms and consisted of 100ms of pre-stimulus presenta-
tion, 500ms of stimulus presentation, and 1000ms of stim-
ulus recording. The intertrial interval was 500 to 700ms.
Data for a participant were included for analysis if there
were at least 10 artifact-free trials for each of the three
stimulus types: block 1 Go trials, block 2 Go trials, and
block 2 No-Go trials.
For the ERP analysis, window time was selected to
establish where to determine the components of interest,
which were identified relative to the number of major posi-
tive and negative peaks following stimulus onset. All time
window values were relative to stimulus onset, and the
peak amplitudes were calculated relative to the baseline
amplitude. Statistical analyses were conducted with SPSS
software version 15.0.1 (SPSS Inc., Chicago, IL, USA).
Behavioral measures were reaction time and accuracy.
Electrophysiological measures were peak amplitude and
latency for N2 and amplitude for P300. Covariates that
indicated group differences (other than infancy hematol-
ogy, which defined the groups) were considered in sub-
sequent analyses as potential confounders (see Table I).
Since several covariates were intercorrelated (i.e. socio-eco-
nomic status [SES; a social class index measured by the
Graffar scale], parental education, maternal depression, and
presence of father), we included SES as the family back-
ground covariate. All models included SES, sex, and 10-
year iron status. When omnibus analyses of variance
What this paper adds
• Ten-year-old children who had IDA in infancy had poorer behavioral perfor-
mance in inhibitory control.
• Affected children showed electrophysiological evidence of poorer responses
in inhibition and control.
• Results provide support for the hypothesis of long-term neurofunctional
alterations with IDA in infancy.
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(ANOVAs) revealed significant main effects or interactions,
post–hoc paired t-tests were conducted using Bonferroni
correction for multiple comparisons. All significance tests
were two-tailed; a p-value  0.05 was considered statisti-
cally significant. The within-participants factor was condi-
tion (block 1 Go, block 2 Go, and block 2 No-Go), and
between-participants factor was group (comparison, former
IDA).
RESULTS
Of 219 children, 132 had satisfactory ERP data for analy-
sis (69 former IDA [65 males, 4 females] and 63 compari-
son children [41 males, 22 females]). Controlling for sex
and SES, there were no group differences in the propor-
tion of children with or without usable ERP data. Back-
ground characteristics for the 69 participants with
previous IDA and 63 comparison participants are shown
in Table I.
ERP outcomes
Table II summarizes the mean peak amplitude and latency
to peak of N2 and P300 components for each type of con-
dition (block 1 Go, block 2 Go, block 2 No-Go).
P300 component
Mean amplitude
The P300 showed the greatest amplitude at the midline
parietal region. The amplitudes were significantly greater
in the block 2 No-Go trials than in the block 2 Go and
block 1 Go trials (p<0.001 for both comparisons;
Table II). No covariates were significant in the final
model. There was a main effect of group: amplitude was
smaller in children who had IDA in infancy than in com-
parison participants (mean [SE] 4.5μV [0.8] vs 7.6μV [0.9];
95% CI for group difference 5.5 to 0.5). Block 2
No-Go trials showed the most marked difference (10.5μV
[1.0] vs 7.7μV [0.9], 95% CI for group difference 0.2–5.5;
see Fig. 1).
Table I: Sample characteristics of participants in infancy and at 10 years
Group (n)a
Comparison (n=63) Former IDA (n=69) Mean difference (95% CI)
Child
Age at test 10y (1mo) 10y (1mo) 0.1mo (–0.3 to 0.6mo)
Sex Male/Female (n) 41/22 65/4 –0.2 (–0.4 to –0.1)b
Birthweight (g) 3573.2 (402.7) 3498.7 (370.2) 74.5 (–58.6 to 207.6)
Gestational age (wks) 39.6 (1.2) 39.3 (1.0) 0.3 (–0.0 to 0.7)c
Height-for-age z-score at 10y 0.10 (0.79) 0.09 (0.97) 0.02 (–0.29 to 0.33)
Weight-for-age z-score at 10y 0.59 (0.96) 0.66 (1.01) –0.07 (–0.41 to 0.28)
Body mass index (kg/m2) at 10y 19.6 (3.2) 19.8 (3.5) –0.2 (–1.4 to 1.0)
Head circumference (cm) at 10y 54.1 (1.4) 54.4 (1.6) –0.2 (–0.8 to 0.3)
IQ, Wechsler Intelligence Scale for Children 90.2 (16.1) 87.8 (17.9) 2.4 (–3.6 to 8.3)
Iron status in infancy
Hemoglobin (g/l) 124.7 (7.1) 102.6 (7.4) 22.1 (19.6 to 24.6)b
Mean corpuscular volume (fl) 75.5 (3.4) 66.6 (4.8) 8.9 (7.4 to 10.3)b
Free erythrocyte protoporphyrin (μg/dl) 86.8 (22.4) 170.7 (74.6) –83.8 (–103.2 to –64.5)b
Ferritin (μg/l) 15.4 (11.3) 6.2 (6.1) 9.2 (6.0 to 12.2)b
Iron status at 10y
Hemoglobin (g/l) 136.9 (8.8) 131.6 (8.9) 5.3 (1.9 to 8.7)b
Mean corpuscular volume (fl) 82.6 (3.6) 80.2 (3.8) 2.4 (1.0 to 3.8)b
Transferrin saturation (%) 28.0 (10.7) 24.3 (11.3) 3.7 (–0.8 to 8.2)
Free erythrocyte protoporphyrin (μg/dl) 65.2 (15.4) 71.1 (14.0) –5.9 (–11.6 to –0.3)d
Ferritin (μg/l) 29.0 (12.0) 27.4 (13.0) 1.6 (–4.0 to 7.2)
Family
Maternal IQe 83.9 (11.7) 83.4 (9.6) 0.4 (–3.4 to 4.3)
Maternal education, y 9.8 (3.0) 9.0 (3.0) 0.9 (–0.2 to 1.9)
Paternal education, y 10.4 (2.7) 9.3 (3.0) 1.1 (0.1 to 2.1)d
Father present, % (n) 87 (53) 68 (46) 0.19 (0.05 to 0.34)d
Social class indexf 32.3 (7.2) 35.0 (6.8) –2.6 (–5.1 to –0.2)d
Life stressg 4.6 (2.5) 5.2 (2.6) –0.6 (–1.4 to 0.3)
Home environmenth 37.8 (7.5) 35.8 (7.6) 2.0 (–0.7 to 4.6)
Maternal depressioni 15.0 (12.0) 20.8 (15.0) –5.8 (–10.6 to –1.0)d
aNumbers vary slightly owing to occasional missing data for some measures. bp 0.01. cp 0.10. dp 0.05. eMaternal IQ was measured
with an abbreviated version of the Wechsler Adult Intelligence Scale-Revised. fMeasured by the Graffar scale, designed to differentiate
families at the lower end of the socio-economic spectrum. gMeasured by a scale modified from Holmes and Rahe. hMeasured by the Home
Observation for Measurement of the Environment-Revised.26 iMeasured by Center for Epidemiologic Studies Depression Scale.27 Values
given are means (SD) for continuous variables and percentages (n) for categorical variables.
Table II: Mean (SD) peak amplitude and latency to peak of N2 and P300
components for each condition
Condition Block 1 – Go Block 2 – Go Block 2 – No-Go
N2 amplitude (μV) –10.4 (6.2) –12.6 (6.8)a –8.6 (6.9)
N2 latency (ms) 381.7 (57.7) 353.6 (39.5)a 370.6 (51.3)a
P300 amplitude (μV) 3.6 (7.3) 5.6 (7.3) 9.1 (7.5)a
ap 0.01.
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N2 component
Peak amplitude
The N2 showed the greatest amplitude at the midline
frontal region. Values were higher in block 2 Go trials
than in block 1 Go and block 2 No-Go trials (p<0.001
for both comparisons; Table II). After controlling for
significant background variables, there were no significant
group differences.
Latency to peak amplitude
Overall, the latency to peak amplitude was shorter in block
2 Go trials than in block 1 Go and block 2 No-Go trials
(p<0.001 for both comparisons; Table II). No covariate
remained significant in the final model. The children who
had IDA in infancy had slower responses than those in the
comparison group (mean [SE] 378.9ms [4.9] vs 356.9ms
[5.0]; 95% CI for group difference 7.5–36.6).
Behavioral outcomes
Accuracy
As expected, participants performed better in block 1 Go
trials than in block 2 Go or block 2 No-Go trials (p<0.01
for both comparisons; Table II). Controlling for sex, there
was a main effect of group: children who had IDA in
infancy were less accurate (mean [SE] 95.4% [0.5] vs
96.9% [0.6]; 95% CI for group difference 3.0–0.1).
Reaction time in conditions 1 and 2
Overall, participants had faster reaction time for block 1
Go trials than for block 2 Go trials (p=0.001; Table II).
No relevant background factors were significant in the final
model; the children who had IDA in infancy were slower
than children in the comparison group (mean [SE]
528.7ms [14.2] vs 485.0ms [15.0]; 95% CI for group differ-
ence 0.9–86.5). When block 1 Go and block 2 Go were
analyzed separately, the difference in reaction time between
children who had IDA in infancy and children in the com-
parison group was significant for block 2 Go trials
(543.9ms [12.7] vs 499.5ms [13.8]; p=0.02; 95% CI for
group difference –81.4 to –7.3; see Fig. 2). The difference
for the block 1 Go trial did not reach statistical signifi-
cance (p=0.14).
The design of the infancy study also raised the question
whether the age at which IDA was detected influenced the
effects. We compared ERP outcomes in the 33 participants
with IDA at 6 months with outcomes in those with IDA at
12 or 18 months (n=82 and n=17 respectively). There were
no statistically significant differences with regard to the
age at which IDA was identified.
DISCUSSION
This study was undertaken to determine whether IDA in
infancy affected cognitive inhibitory control and response
inhibition in the long term. We found that, despite iron
treatment in infancy, 4 years of formal schooling, and
absence of IDA at the age of 10 years, children who had
IDA in infancy performed worse on the Go/No-Go task
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Figure 1: Topographic distribution of scalp potentials collapsed across
block 1 Go, block 2 Go, and block 2 No-Go. (a) Comparison participants.
(b) Children who had iron-deficiency anemia (IDA) in infancy.
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Figure 2: Reaction time (all conditions) in children who had iron-
deficiency anemia (IDA) in infancy and comparison participants (p=0.02).
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than comparison participants. The study may help under-
stand specific differences in brain system functioning in
children who had IDA in infancy, which could underlie
more global cognitive and behavioral dysfunctions.15 Such
dysfunctions include alterations in motor activity and sleep
patterns14,15 and poorer overall cognitive, motor, and
social-emotional functioning16 observed years after iron
treatment.
IDA in infancy could affect diverse brain functions
through different pathways. Iron is involved in the biosyn-
thesis of lipids, which are important substrates for cell
membranes and the synthesis and metabolism of myelin.17
Iron is an essential component of cytochrome oxidase,
which is thought to reflect neuronal metabolism, and is a
cofactor in several enzymes involved in neurotransmitter
metabolism. Dopamine is the neurotransmitter that has
been studied the most in rodent models of dietary iron
deficiency. There is evidence of alterations in dopamine
transporter and D2 receptors that persist in spite of treat-
ment.5,15 Other monoamine and non-monoamine neuro-
transmitters are also affected.18
P300 component
We found that the children who had IDA in infancy
showed a smaller P300 amplitude, primarily in the inhibi-
tory block 2 No-Go trials. There is general agreement that
the P300 amplitude reflects the neural resources used for
evaluating the response to an instructional task. For correct
performance when a No-Go trial is presented, it is neces-
sary to update the context and inhibit the prepotent
response.9 An increase in P300 amplitude is expected and
appears to reflect the increased activation of the neural
circuits involved in these processes.13,19 The natural matu-
ration of the P300 wave is a reduction in amplitude and
latency from childhood to adolescence owing to fine-tun-
ing of cognitive networks with pruning of synapses and
increased myelination of the prefrontal cortex and its con-
nections.12,19 However, smaller P300 amplitude has been
described as a feature of psychiatric and developmental dis-
orders.20,21 Pharmacological manipulations that decrease
dopaminergic activity reversibly impair the P300 in both
patients with Parkinson disease and healthy participants.21
Furthermore, the D2 dopamine receptor (DRD2) gene,
specifically the A1+ genotype, has been associated with
prolonged latency of the P300 in 12-year-old males and an
interaction with stress for reduced P300 amplitude.19 Some
researchers suggest that a smaller P300 could be used as a
predictor of subsequent problems in children at risk of dis-
orders of disinhibition. Prospective studies have found that
a smaller P300 amplitude in children predicted later ado-
lescent alcohol and substance abuse,22 conditions in which
the dopamine system is strongly implicated. Our finding of
smaller P300 amplitude in children who had IDA in
infancy appears to be consistent with long-lasting dysfunc-
tion of the dopamine system and, consequently, the brain
networks involving this neurotransmitter.
N2 component
In the present study, the N2 peak amplitude was greater in
block 2 Go trials than No-Go trials, and there were no
significant group differences. The N2 is generally consid-
ered an electrophysiological marker of attentional control.
It is often enhanced under a condition in which there is a
tendency to make a prepotent but incorrect response. In
several adult studies, the No-Go-N2 has been found to be
strongly enhanced compared with Go trials. Our finding of
no enhancement of the No-Go-N2 might, therefore,
appear puzzling. However, the No-Go-N2 is not enhanced
in some pathological conditions such as depression or
attention-deficit–hyperactivity disorder.23 Other factors
may also explain why we did not observe enhanced
No-Go-N2 or group differences. One possibility is the
design of the task. Stimuli were presented on-screen for a
relatively long time, allowing ample opportunity for
responding with little or no speed pressure. A recent study
showed that speed pressure modulates the response and
contributes to the final amplitude of the N2. Without time
pressure, there was no enhancement of N2, whether mea-
sured by amplitude or latency.24 Age is another important
factor, as developmental studies have shown that children
do not demonstrate a large difference in N2 amplitude
until adolescence.12
In contrast to the absence of group differences in ampli-
tude, we found that the comparison group had shorter N2
latency, in keeping with the behavioral response. This find-
ing is consistent with a myelination dysfunction in children
who had IDA in infancy, here reflected by longer N2
latency.
Accuracy rates were high in both groups, perhaps
because of the relatively long response time allowed. That
response window may have led to a ceiling effect for the
number of correct responses for many in our sample.
However, in spite of the relatively easy scenario, children
who had IDA in infancy demonstrated worse performance.
The lack of a sex effect is noteworthy in light of studies
showing that development of gray and white matter in the
prefrontal cortex peaks in females before adolescence.25
With respect to reaction time, both groups showed, for
correct responses, shorter reaction time for block 1 Go tri-
als than for block 2 Go trials. Nevertheless, the children
who had IDA in infancy showed significantly longer reac-
tion time than children in the comparison group. The
longer N2 latency in the children who had IDA in infancy
seems to be in keeping with these behavioral results. We
previously showed that IDA in infancy is associated with
longer auditory and visual evoked potential latencies at age
4 years, suggesting impaired myelin development.14 The
reaction time and latencies results are consistent with long-
lasting effects of early IDA on myelination.
Study limitations
This study has several limitations. It cannot prove that
IDA in infancy was the cause of altered ERP and behav-
Iron-Deficiency Anemia and Cognitive Inhibitory Control Cecilia Algarın et al. 457
ioral responses, nor can it exclude the possibility of
unidentified factors that may underlie both IDA and cogni-
tive alterations. Although we consider some ways that IDA
could have long-lasting effects, the mechanisms remain
unclear. This study has more detailed information on the
timing of IDA than most previous studies, but prenatal
iron status was not determined. However, given the study
design, no child had IDA in infancy for more than
6 months. The study also cannot determine whether the
poorer cognitive inhibitory control in the children who
had IDA in infancy will affect later cognitive functioning
or scholastic achievement. Nonetheless, our findings are
worrying and warrant continued follow-up. If the observed
alterations have functional effects with advancing age, IDA
in infancy may turn out to be important in understanding
processes that underlie cognitive limitations in adulthood.
CONCLUSION
The results of this study extend our previous findings that
early IDA is associated with altered neurofunctional devel-
opment at preschool age.14 IDA in infancy appears to
affect the efficiency of the neural systems underlying inhib-
itory control at the age of 10 years. Alterations of dopa-
mine system functioning could be implicated in a smaller
amplitude of the P300. Delayed myelination could contrib-
ute to longer reaction times and latencies. The combined
effects could impair inhibitory control and response inhibi-
tion. We suggest that these subtle changes contribute to
the limitations of cognitive development in children who
experienced IDA in infancy. Since IDA in infancy contin-
ues to be common on a global basis,15 preventing it may
improve the neurodevelopment of millions of the world’s
most vulnerable children.
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